Ahmedabad, India headquartered pharmaceutical firm Zydus Cadila announced that its Covid-19 plasmid DNA vaccine ZyCoV-D will be manufactured in Korea by two firms - Enzychem Lifesciences and Hanmi Pharmaceutical. The firms have begun the optimization process for transferring technology and setting up production facilities to manufacture the Indian-developed vaccine starting...
India Approves DNA Vaccine for Covid-19
Gujarat India based Zydus Cadila's Covid-19 vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organization (CDSCO) which is India's regulator. The DNA vaccine, developed in partnership with India's Department of Biotechnology,...
Zydus Cadila Wins Pharma Patent Lawsuit in the U.S.
The U.S. Court of Appeals for the Federal Circuit has affirmed judgement in favor of Zydus Pharmaceuticals (USA) Inc., holding that its proposed generic version of Lialda does not infringe a U.S. Patent. Zydus is the first pharmaceutical company to file an abbreviated new drug application for a generic version...